Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Ustekinumab and Omalizumab

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 2 releases in its history.

Award

11 Sep 2024 at 01:00

OJEU - F3 - Contract Award Notice
Tender

28 Jun 2024 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), has completed the procurement process for the supply of Ustekinumab and Omalizumab to NHS Scotland. The tender, conducted via an open procedure, falls under the healthcare industry category and covers all entities under the National Health Service (Scotland) Act 1978, as well as Integrated Joint Boards formed under the Public Bodies (Joint Working) Scotland Act 2014. The procurement process, which commenced in June 2024 and concluded with the award in August 2024, has culminated in contracts being awarded to multiple suppliers for two distinct lots, each for a period extending up to 24 months with possible extensions.

This tender presents significant opportunities for businesses in the pharmaceutical sector, particularly those specialising in biopharmaceuticals and healthcare supplies. The framework agreement allows for multiple suppliers, encouraging participation from large corporations and SMEs alike. The procurement process emphasised both quality and pricing, making it suitable for businesses with robust quality control systems and competitive pricing strategies. Suppliers can benefit from a substantial contract value and the potential for long-term engagement with NHS Scotland, fostering growth and market presence in the UK healthcare sector.

How relevant is this notice?

Notice Information

Notice Title

Ustekinumab and Omalizumab

Notice Description

Supply of Ustekinumab and Omalizumab to NHS Scotland

Lot Information

Ustekinumab

Supply of Ustekinumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to a six (6) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Omalizumab

Supply of Omalizumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000770683
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP514073
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£70,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£13,816,578 £10M-£100M

Notice Dates

Publication Date
11 Sep 20241 years ago
Submission Deadline
29 Jul 2024Expired
Future Notice Date
Not specified
Award Date
21 Aug 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
7
Supplier Names

Accord Healthcare Ltd

Amgen Ltd

Celltrion Healthcare United Kingdom Limited

Janssen-Cilag Ltd

Novartis Pharmaceuticals UK Ltd

STADA UK - Thornton & Ross

Sandoz

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...